| PubMed |
Abstract |
RScore(About this table) |
| 19034645 |
Cochran S, Li CP, Ferro V: A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins. Glycoconj J. 2009 Jul;26(5):577-87. Epub 2008 Nov 26.
The assay is applicable to a wide variety of heparin/HS-binding proteins of diverse structure and function (e.g., FGF-1, FGF-2, VEGF, IL-8, MCP-2, ATIII, PF4) and to ligands of varying molecular weight and degree of sulfation (e.g., heparin, PI-88, sucrose octasulfate, naphthalene trisulfonate) and is thus well suited for the rapid screening of ligands in drug discovery applications. |
31(0,1,1,1) |
Details |
| 19815812 |
Meis S, Hamacher A, Hongwiset D, Marzian C, Wiese M, Eckstein N, Royer HD, Communi D, Boeynaems JM, Hausmann R, Schmalzing G, Kassack MU: NF546 [4,4'-(carbonylbis (imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenyle ne)-carbonylimino))-bis (1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells. J Pharmacol Exp Ther. 2010 Jan;332(1):238-47. Epub 2009 Oct 8.
|
3(0,0,0,3) |
Details |
| 18922933 |
Subramaniam D, Giridharan P, Murmu N, Shankaranarayanan NP, May R, Houchen CW, Ramanujam RP, Balakrishnan A, Vishwakarma RA, Anant S: Activation of apoptosis by 1-hydroxy-5,7-dimethoxy-2-naphthalene-carboxaldehyde, a novel compound from Aegle marmelos. Cancer Res. 2008 Oct 15;68(20):8573-81.
Immunostaining for CD31 showed that there was a significant reduction in microvessels in the HDNC-treated animals, coupled with decreased cyclooxygenase-2, interleukin-8, and vascular endothelial growth factor mRNA. |
1(0,0,0,1) |
Details |